MedPath

Way to Be Active III (Framing Incentives)

Not Applicable
Completed
Conditions
Sedentary Lifestyle
Registration Number
NCT02030119
Lead Sponsor
University of Pennsylvania
Brief Summary

Employers are increasingly looking for opportunities to motivate sedentary employees to become more physically active. Workplace walking programs have had mixed success and typically show most improvement among participants that are already fairly active at a baseline. The goal of this study is to determine whether a financial incentive program can motivate sedentary employees to increase the number of steps they walk per day to meet a minimum threshold.

The primary outcome measure is the proportion of days a minimum activity of 7000 steps or more is achieved. Outcomes will be assessed each week for 3 months using incentives followed by 3 months of follow-up without incentives. Secondary outcomes will include the average steps walked per day.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
281
Inclusion Criteria
  1. Age greater than 18.
  2. Participant will need an iPhone or Android smartphone to be able to use the Moves App for tracking steps
Exclusion Criteria
  1. A score of "high" on the International Physical Activity Questionnaire (IPAQ) activity level scale
  2. BMI less than 27
  3. Pregnant or lactating
  4. Participation in another physical activity study

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Proportion of Days Each Individual Walks 7000 Steps Per Day or MoreThroughout the 6 month study

The primary outcome measure is the mean proportion of participant-days a minimum activity of 7000 steps or more is achieved. Outcomes will be assessed each week for 3 months using incentives followed by 3 months of follow-up without incentives.

Secondary Outcome Measures
NameTimeMethod
Average Number of Steps Per DayThroughout the 6 month study

Secondary outcomes include average number of steps each individual takes per day throughout the 13-week intervention and additional 13-week follow-up periods.

Trial Locations

Locations (1)

University of Pennsylvania

🇺🇸

Philadelphia, Pennsylvania, United States

University of Pennsylvania
🇺🇸Philadelphia, Pennsylvania, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.